used in classic Chinese, Ayurvedic, and Thai medication. Conolidine could represent the start of a fresh period of Continual pain management. It is currently becoming investigated for its consequences over the atypical chemokine receptor (ACK3). In the rat design, it was identified that a competitor molecule binding to ACKR3 resulted in inhibition